Ibex Medical Analytics

Our 2024 Patient Insight Report on Cancer Diagnostics revealed 62% of Americans are concerned that they or a loved will be diagnosed with cancer in the near future, and 89% of respondents reported a need for better technology to help diagnose cancer. Explore key insights from our survey and read the full report at https://lnkd.in/eeYatJZm to understand how we can address these concerns and advance the standards of cancer diagnosis. #cancerdiagnostics #AI #diagnosticaccuracy #digitaltransformation

The conversation around AI in healthcare will only continue to expand in 2025. As Dr. Cornelia C. Walther at Forbes explains, "Preventive interventions can save lives and resources while increasing the quality of life of humans." AI, with a human in the loop, is always the best combination. Serving patients and making a difference in their lives continues to drive our innovation forward. More on her piece here: https://lnkd.in/eJgFMW9z

As we near the end of 2024, the Ibex team is thankful for our customers and partners around the world working to ensure all patients have trusted cancer diagnostics. We wish you a happy holiday season and joyful new year & we look forward to furthering our mission together in 2025!

In a KLAS Research Report, 100% of Ibex customers said they would purchase Ibex's solution again. We're honored to support pathologists around the world with our #AI-powered tools that assist with #cancer diagnosis. Review the complete report for more direct feedback from our customers: https://lnkd.in/du_JqQC5 #KLASresearch #digitalpathology #healthcareAI #AI #cancerdiagnosis #pathology

Thrilled to see NHS Wales recognized for their trailblazing efforts to use AI-powered tools to transform cancer diagnostics across the entire country. Congratulations Betsi Cadwaladr University Health Board & SBRI Centre of Excellence for paving the way and ensuring everyone in Wales receives the highest quality of care! #digitalpathology #pathology #cancerdiagnostics https://lnkd.in/gsh3aku7

A few years back, one of our leaders came across an eye-opening article about AI in prostate cancer diagnostics by Ibex Medical Analytics and UPMC. It was a game-changer in the field, and we were inspired by how AI could transform pathology. That was the spark we needed to start leading our journey of incorporating cutting-edge technology to enhance diagnostic accuracy and patient care. Thank you for being part of our journey as we continue to innovate and push the boundaries of healthcare technology 💡 Curious about how we use AI in patient care? Check out our website www.corepluspr.com #diagnosticomedico #laboratorioclinico #saludybienestar #IAensalud #inteligenciaartificial #saludpr #saludprofesional #profesionalesdelasalud

AI-powered cancer diagnostics is not the future - it is the present! We were excited to see Ibex customers share how #AI has improved their turn around times and workflow efficiencies at Global Engage's Digital Pathology & AI Congress last week in London. Thank you to Dr. David Clark, Nottingham University Hospitals NHS Trust, & Dr. Paida Gwiti, North West Anglia NHS Foundation Trust, for presenting their laboratories' digital pathology journeys and the benefits of AI-powered diagnostic workflows. Learn more about North West Anglia NHS Foundation Trust experience with Ibex's AI here: https://lnkd.in/esMmH4r3 #digitalpathology #pathology #cancerdiagnostics

As cancer rates climb and resources are stretched, Wales is setting a benchmark in healthcare innovation by harnessing artificial intelligence and big data to support early cancer detection and diagnosis. In our latest article in The Telegraph, Healthcare Market Analyst Thomas Burden highlights the impact of digital infrastructure and how it's transforming traditional practices across pathology and genomic analysis. Read the full digital article here: https://lnkd.in/ezu3dpzu Ibex Medical Analytics Betsi Cadwaladr University Health Board SAIL Databank Cari-Anne Quinn Dr Chris Martin DL Llywodraeth Cymru / Welsh Government #HealthcareInnovation #ArtificialIntelligence #BigData #CancerCare #LifeSciences #FutureOfHealthcareCampaign2024 #AIHealthCareWales

In his recent article, our CEO Joseph (Yossi) Mossel highlights that uncertainty in cancer diagnosis is a significant concern in today’s healthcare landscape. He underscores the urgent need for precision in diagnostics and the encouraging rise in trust for AI as a tool to improve accuracy. By embracing AI-driven solutions, we can reshape the diagnostic landscape and ensure that all patients receive timely and equitable care.   Read the full article below to learn more:

Yesterday at the SABCS, Prof. savitri krishnamurthy of MD Anderson Cancer Center, Prof. Anne Vincent-Salomon of Institut Curie & Ibex's Manuela Vecsler, PhD presented new data from an early evidence program showing pathologists supported by Ibex Breast HER2 had improved accuracy and consistency of HER2 scores. The mulit-site validation study included breast biopsies and excisions of nearly 2,000 patients from 12 international cancer centers and laboratories in the US, EU, UK and Brazil. Link to view the research below 👇 stuart schnitt - Brigham and Women's Hospital, Elena Provenzano - Cambridge University Hospitals NHS Foundation Trust, Rita Canas Marques -Champalimaud Foundation, Laurent Arnould - Center Georges-Francois Leclerc, gaetan macgrogan - Institute Bergonié, Elisabeth Shearon - Alverno Laboratories, Derek Welch & Pranil Chandra - PathGroup, Piotr Borkowski MD - Quest Diagnostics, Sabine Declercq - ZAS - Ziekenhuis aan de Stroom, Joseph Loane - NHS Greater Glasgow and Clyde, Anu Gunavardhan - Betsi Cadwaladr University Health Board, Luca Di Tommaso - Humanitas Research Hospital, Vitor Krauss - Diagnosticos Da America S A Brazil, Jeanne Thomassin - MEDIPATH FRANCE, Marie Brevet - Cypath #SanAntonioBreastCancerSymposium #digitalpathology #breastcancer #pathology #precisiononcology